Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 48 (USP48; also known as USP31) is a member of the ubiquitin-specific protease (USP) family of deubiquitinating enzymes that specifically hydrolyze the peptide bond at the C-terminal glycine of ubiquitin and remove ubiquitin moieties from target proteins. USP48 is predominantly localized in neuronal nuclei due to a conserved nuclear localization signal, where it tightly regulates synaptic development and plasticity by interacting with and deubiquitinating key signaling molecules such as NF-κB subunit p65. This stabilization increases NF-κB transcriptional activity and affects the expression of genes implicated in synapse pruning. USP48 also plays a regulatory role in cell cycle progression by stabilizing proteins like Aurora B kinase, in DNA damage response as a histone H2A deubiquitinase counteracting BRCA1-mediated chromatin modification, and in modulating apoptosis and photoreceptor homeostasis. Mutations or dysregulation of USP48 are causally linked to endocrine tumors (notably Cushing’s disease), cancer, Fanconi anemia, and neurodevelopmental as well as neurodegenerative diseases. USP48’s activity is essential for genomic maintenance, proper neural circuit assembly, and immune response regulation, positioning it as a potentially significant therapeutic target in oncology, neurobiology, and inflammation.
Small molecule inhibition of deubiquitinating activity (theoretical; various DUB inhibitors exist but none reported specific for USP48) Modulation of downstream protein stability or signaling (by inhibition/activation of USP48)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 48 (USP48).